Co-Authors
This is a "connection" page, showing publications co-authored by Heinz Feldmann and Elaine Haddock.
Connection Strength
2.229
-
Inactivation of SARS-CoV-2 Laboratory Specimens. Am J Trop Med Hyg. 2021 04 20; 104(6):2195-2198.
Score: 0.941
-
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. JCI Insight. 2020 12 03; 5(23).
Score: 0.229
-
Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system. Antivir Ther. 2020; 25(4):223-231.
Score: 0.215
-
Gamma Irradiation as an Effective Method for Inactivation of Emerging Viral Pathogens. Am J Trop Med Hyg. 2019 05; 100(5):1275-1277.
Score: 0.205
-
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets. Antiviral Res. 2018 08; 156:64-71.
Score: 0.193
-
Domestic Pig Unlikely Reservoir for MERS-CoV. Emerg Infect Dis. 2017 06; 23(6):985-988.
Score: 0.180
-
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus. JCI Insight. 2021 05 24; 6(10).
Score: 0.059
-
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model. Nat Commun. 2021 04 16; 12(1):2295.
Score: 0.059
-
Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques. Front Immunol. 2018; 9:205.
Score: 0.047
-
Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 2014 Aug; 10(8):e1004250.
Score: 0.037
-
The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS One. 2013; 8(7):e69127.
Score: 0.034
-
Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). J Immunol Methods. 2011 May 31; 368(1-2):24-35.
Score: 0.029